RT @FuenteApolo: #Radonc #SRS postsurgery #brainmetastases https://t.co/tfzQsHXV1R
RT @JNeurooncol: "Postop fractioned stereotactic radiotherapy remains a viable option to radiosurgery, specially in large cavities. A group…
#Radonc #SRS postsurgery #brainmetastases
RT @JNeurooncol: "Postop fractioned stereotactic radiotherapy remains a viable option to radiosurgery, specially in large cavities. A group…
RT @JNeurooncol: "Postop fractioned stereotactic radiotherapy remains a viable option to radiosurgery, specially in large cavities. A group…
RT @JNeurooncol: "Postop fractioned stereotactic radiotherapy remains a viable option to radiosurgery, specially in large cavities. A group…
RT @JNeurooncol: "Postop fractioned stereotactic radiotherapy remains a viable option to radiosurgery, specially in large cavities. A group…
RT @JNeurooncol: "Postop fractioned stereotactic radiotherapy remains a viable option to radiosurgery, specially in large cavities. A group…
RT @JNeurooncol: "Postop fractioned stereotactic radiotherapy remains a viable option to radiosurgery, specially in large cavities. A group…
RT @JNeurooncol: "Postop fractioned stereotactic radiotherapy remains a viable option to radiosurgery, specially in large cavities. A group…
RT @JNeurooncol: "Postop fractioned stereotactic radiotherapy remains a viable option to radiosurgery, specially in large cavities. A group…
"Postop fractioned stereotactic radiotherapy remains a viable option to radiosurgery, specially in large cavities. A group from @UWCarbone evaluated their outcomes with this method. Full text: https://t.co/creQH0LeAO” https://t.co/BB1Z2FqY2r
Impact of adjuvant fractionated stereotactic radiotherapy dose on local control of brain metastases. https://t.co/TZgzfql4h1 h/t @NCBI #RadOnc #PubMed